The Usefulness of Pleural Lactate Measurement for Differentiating Transudate and Exudate
Öz
Our study aimed to evaluate pleural lactate levels, to identify the reliability and validity of determining pleural fluid quality in patients with pleural effusion.This is a prospective, observational study conducted on patients who were admitted to a university hospital between July 1, 2017, and January 31, 2018, and diagnosed with pleural effusion. Pleural fluid classification into transudates and exudates was made according to Light’s criteria. The study group consisted of a total of 169 patients with pleural effusion, [99 (58.6%) male and aging 18-93 years (mean ± SD, 64.6 ± 16.1 years)]. Forty-four (26%) of the patients were evaluated as exudate and 125 (74%) as transudate. The median value of lactate was 3.20 mmol/L (min-max: 0.90-14.3) in exudate patients and 1.85 mmol/L (min-max: 0.90-4.70) in transudate patients, and a significant difference was detected in the comparison of both (z: 5.894; p<0.001). There was a positive correlation between pleural lactate levels and pleural LDH, pleural LDH/serum LDH and pleural protein/serum protein ratios. The cut-off value of the pleural fluid lactate level was determined to be 2.0 for the highest sensitivity and specificity (sensitivity: 85%, specificity: 64%; AUC: 0.799). Measurement of lactate levels in pleural fluid can be useful for the differentiation of transudate and exudate fluid. Moreover, detection of lactate levels in a very short period may provide a more useful screening tool compared to other strategies.
Anahtar Kelimeler
Destekleyen Kurum
Proje Numarası
Teşekkür
Kaynakça
- Cohen, M and S A Sahn, Resolution of pleural effusions. Chest, 2001. 119: 1547. 2. Yu, H. Management of pleural effusion, empyema, and lung abscess. in Seminars in interventional radiology. 2011. Thieme Medical Publishers. 3. Light, R W, J T Rogers, J P Moyers, Y C Lee, R M Rodriguez, W C Alford, Jr., et al., Prevalence and clinical course of pleural effusions at 30 days after coronary artery and cardiac surgery. Am J Respir Crit Care Med, 2002. 166: 1567-71. 4. M, M, Epidemiology of pleural effusion. Eur Respir Mon, 2002. 22: 146-156. 5. Valdes, L, D Alvarez, J M Valle, A Pose, and E San Jose, The etiology of pleural effusions in an area with high incidence of tuberculosis. Chest, 1996. 109: 158-162. 6. Anchinmane, V T and G V Puranik, The Diagnostic Separation of Transudates and Exudates in Ascitic Fluid and Pleural Fluid. Bombay Hospital Journal, 2011. 53: 166. 7. Light, R W, M I Macgregor, P C Luchsinger, and W C Ball, Pleural effusions: the diagnostic separation of transudates and exudates. Annals of internal medicine, 1972. 77: 507-513. 8. Mental health of older adults. 2017 16 March 2018]; Available from: http://www.who.int/en/news-room/fact-sheets/detail/mental-health-of-older-adults. 9. Bonita, R, R Beaglehole, and T Kjellström 2nd, Basic epidemiology 2nd edition, in WHO, Geneva. 2006. 10. Sahn, S A and J E Heffner, Pleural fluid analysis, in Textbook of pleural diseases. 2008. p. 209-226. 11. Romero-Candeira, S, L Hernández, S Romero-Brufao, D Orts, C Fernández, and C Martín, Is it meaningful to use biochemical parameters to discriminate between transudative and exudative pleural effusions? Chest, 2002. 122: 1524-1529. 12. Yang, W, B Zhang, and Z M Zhang, Infectious pleural effusion status and treatment progress. J Thorac Dis, 2017. 9: 4690-4699. 13. Kim, H H, J H Chung, D M Kim, N R Yun, J Lee, Y E Kwon, et al., The clinical characteristics of pleural effusion in scrub typhus. BMC Infect Dis, 2016. 16: 278. 14. Villena, V, A E López, J Echave-Sustaeta, C M Alvarez, and P E Martín, Prospective study of 1,000 consecutive patients with pleural effusion. Etiology of the effusion and characteristics of the patients. Archivos de bronconeumologia, 2002. 38: 21-26. 15. Yeo, C D, J W Kim, M R Cho, J Y Kang, S J Kim, Y K Kim, et al., Pleural fluid pentraxin-3 for the differential diagnosis of pleural effusions. Tuberculosis and respiratory diseases, 2013. 75: 244-249. 16. Aydin, Y, A Turkyilmaz, Y S Intepe, and A Eroglu, Malignant pleural effusions: appropriate treatment approaches. Eurasian J Med, 2009. 41: 186-93. 17. Maranhão, B H F, C T d Silva Junior, A M d S Chibante, and G P Cardoso, Determination of total proteins and lactate dehydrogenase for the diagnosis of pleural transudates and exudates: redefining the classical criterion with a new statistical approach. Jornal Brasileiro de Pneumologia, 2010. 36: 468-474. 18. Burgess, L J, F J Maritz, and J F Taljaard, Comparative analysis of the biochemical parameters used to distinguish between pleural transudates and exudates. Chest, 1995. 107: 1604-1609. 19. 20. 21. Bonita, R, R Beaglehole, and T Kjellström. Basic Epidemiology. [cited 2018 25 March]; 2nd Edition:[Available from: http://apps.who.int/iris/bitstream/handle/10665/43541/9241547073_eng.pdf;jsessionid=F5E88F4EB3C9F547AEA0C00ABD983046?sequence=1. 20. Baratloo, A, M Hosseini, A Negida, and G El Ashal, Part 1: simple definition and calculation of accuracy, sensitivity and specificity. 2015.
Ayrıntılar
Birincil Dil
İngilizce
Konular
Sağlık Kurumları Yönetimi
Bölüm
Araştırma Makalesi
Yazarlar
Rıdvan Çevlik
0000-0001-6294-4443
Türkiye
Engin Özakın
*
0000-0003-4301-5440
Türkiye
Huseyin Yildirim
Bu kişi benim
0000-0003-2332-9039
Türkiye
Esref Genc
Bu kişi benim
0000-0002-8647-1780
Türkiye
Nurdan Acar
0000-0002-3532-1803
Türkiye
Filiz Kaya
0000-0002-4864-9453
Türkiye
Yayımlanma Tarihi
7 Mayıs 2021
Gönderilme Tarihi
10 Haziran 2020
Kabul Tarihi
2 Kasım 2020
Yayımlandığı Sayı
Yıl 2021 Cilt: 43 Sayı: 3